Japan Apheresis Market Size, Share and Market Forecast to 2029 | COVID-19 Impact Analysis | DataMIntelligence
Market Overview
The Japan apheresis market size was worth $ YY million in 2018 and is estimated to reach $ YY million by 2029, at a CAGR of 6.5% during the forecast period (2021-2029).
Apheresis is a medical procedure to remove the whole blood from a donor and separate the blood into individual components so that one particular component can be removed. The remaining blood components then are re-introduced back into the bloodstream of the patient or donor.
Download free sample @ https://bit.ly/3qorpP4
Market Dynamics
Increasing incidence of hematological disorders
Rising advancements in technology
Growing demand for blood plasma in biopharmaceutical companies
Industry Forces
In Japan, the Adacolumn of JIMRO Co., Ltd. (Gunma, Japan) was approved and reimbursed by the Japan Ministry of Health, Labour and Welfare for the treatment of patients with ulcerative colitis, Crohn’s disease and pustular psoriasis.
Diseases to which Plasmapheresis can be applied under Health Insurance in Japan include Myasthenia gravis, Guillan-barre syndrome, Chronic inflammatory demyelinating polyneuropathy, Multiple sclerosis, Systemic lupus erythematosus, Malignant rheumatoid arthritis, Macroglobulinemia, Multiple myeloma, Acquired factor VIII positive hemophilia, Severe blood group incompatibility pregnancy, Hemolytic uremic syndrome, Thrombotic
Thrombocytopenic purpura, Focal segmental glomerular sclerosis, Familial hypercholesterolemia, Arteriosclerosis obliterans, Chronic Hepatitis C, Fulminant hepatitis, Postoperative hepatic failure, acute hepatic failure, Drug intoxication, and Kawasaki disease.
Market Segmentation
- By Product
- By Technology
- By Apheresis Procedure
- By Application
- By End-User
View full report @ https://bit.ly/3woSmWX
By Product – Apheresis Devices
An apheresis machine is a device that receives blood removed from a patient or donor’s body and separates it into its various components: plasma, platelets, white blood cells and red blood cells. The segment growth is attributed to the growing demand for apheresis machines owing to their durability and extensive use in transfusion treatment. In addition, the availability of a higher class of machines for efficient separation of various blood and plasma components will further favour segment growth.
Competitive Landscape
The Japan Apheresis market is highly consolidated with selected key players accounting for predominant market share.
The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the apheresis market in Japan.
Trending Topic’s
Japan Single-Use Bioprocessing Products Market
Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/research-report/japan-apheresis-market
